Friday, October 15, 2021 10:54:15 PM
Cost Savings:------------------------------------------
His office has 6.5 DVM's (Doctor of Vet Medicine) and they each run roughly 15 tests per week (T4/FT4/Cortisol tests). Therefore, his office runs a total of 97.5 test a week. (for these calculations, lets round this number down to 90).
His office saves roughly $25 for each test ($70-$45=$25).
Therefore, his office saves $2,250 a week with running tests with Truforma (97.5 tests x $25) and $117,000 a year. THIS IS SIGNIFICANT and could result in a very quick ROI for the vet offices.
Time Savings:------------------------------------------
His office currently waits 2 days for cortisol test results, 48 hours.
His office estimated it takes roughly 2-4 minutes to set up and 15-20 minutes to run a test. 24 minutes max for a test is a savings of roughly 47.5 hours, 99.2% time savings.
90 tests a week (2,400 minutes (5x8x60)) means a test will be ran every 26 minutes with results immediately shown after the test is ran. This means the Truforma will rarely sit idle, therefore, a potential need for additional machines.
Recent ZOM News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 04:03:02 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 02/20/2024 11:12:44 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:16:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:11:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:07:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:06:12 PM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 12:18:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:22:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:05:49 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM